{
    "clinical_study": {
        "@rank": "42073", 
        "brief_summary": {
            "textblock": "To compare the efficacy of fluconazole versus placebo in preventing the development of\n      active coccidioidomycosis and other systemic fungal infections among HIV-infected patients\n      with CD4 lymphocyte counts < 250 cells/mm3 who are living in the coccidioidal endemic area."
        }, 
        "brief_title": "A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common", 
        "condition": [
            "Mycoses", 
            "HIV Infections", 
            "Coccidioidomycosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Coccidioidomycosis", 
                "Coccidiosis", 
                "Mycoses"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive either fluconazole or placebo daily."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  CD4 count < 250 cells/mm3.\n\n          -  No active coccidioidomycosis or other fungal disease requiring systemic antifungal\n             therapy.\n\n          -  Residence in area considered to be endemic for Coccidioides immitis.\n\n          -  Consent of parent or guardian if under legal age of consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Unable to take oral medication.\n\n          -  Positive serum cryptococcal antigen.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Systemic antifungal therapy.\n\n        Patients with the following prior conditions are excluded:\n\n        History of hypersensitivity to azole or imidazole compounds.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Systemic antifungal agents within 2 weeks prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002325", 
            "org_study_id": "012R", 
            "secondary_id": "R-0266"
        }, 
        "intervention": {
            "intervention_name": "Fluconazole", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fluconazole"
        }, 
        "keyword": [
            "Mycoses", 
            "Fluconazole", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Coccidioidomycosis"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85006"
                    }, 
                    "name": "McDowell Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85723"
                    }, 
                    "name": "Tucson Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rancho Mirage", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92270"
                    }, 
                    "name": "Dr Lawrence Cone"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002325"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Dr Lawrence Cone": "33.74 -116.413", 
        "McDowell Clinic": "33.448 -112.074", 
        "Tucson Veterans Administration Med Ctr": "32.222 -110.926"
    }
}